Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia

Behavioural Pharmacology

Volumn 7, Issue 1, 1996, Pages 3-23

  Sams Dodd, F ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Amphetamine; Clozapine; CPP; Haloperidol; MK 801; Negative symptoms; Postive symptoms; Rat; Social behaviour

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; CLOZAPINE; DEXAMPHETAMINE; DIZOCILPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; AUTOMATION; BEHAVIOR; CONTROLLED STUDY; DRUG INHIBITION; MALE; NEGATIVE SYNDROME; NONHUMAN; PSYCHOSIS; RAT; SCHIZOPHRENIA; SOCIAL ISOLATION; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION; VIDEORECORDING;

EID: 0030071335     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Addington J and Addington D (1991) Positive and negative symptoms of schizophrenia: their course and relationships over time. Schizophrenia Research, 5, 51-59.
2. Allen RM and Young SJ (1978) Phencyclidine-induced psychosis. American Journal of Psychiatry, 135, 1081-1084.
3. Angrist BM and Gershon S (1970) The phenomenology of experimentally induced amphetamine psychosis - preliminary observations. American Journal of Psychiatry, 2, 95-107.
4. Arnt J and Christensen AV (1981) Differential reversal by scopolamine and THIP of antistereotypic and cataleptic effects of neuroleptics. European Journal of Pharmacology, 69, 107-111.
5. Bakker CB and Amini FB (1961) Observations on the psychotomimetic effects of sernyl. Comprehensive Psychiatry, 2, 269-280.
6. Ban TA, Lohrenz JJ and Lehmann HE (1961) Observations on the action of sernyl - a new psychotropic drug. Canadian Psychiatric Association Journal, 6, 150-157.
7. Beamish P and Kiloh LG (1960) Psychoses due to amphetamine consumption. Journal of Mental Science, 106, 337-343.
8. Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. British Journal of Psychiatry, 111, 701-707.
9. Bodi T, Share I, Levy H and Moyer JH (1959) Clinical trials of phencyclidine (sernyl) in patients with psychoneurosis. Antibiotic Medicine and Clinical Therapy, 6, 79-84.
10. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A and Carpenter WT (1994) Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20-26.
11. Bürki HR, Eichenberger E, Sayers AC and White TG (1975) Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal. Pharmakopsychiatry, 8, 115-121.
12. Carlsson M and Carlsson A (1990) Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin, 16, 425-432.
13. Casey D (1993) Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates. Psychopharmacology, 112, S55-S59.
14. Castellani S and Adams PM (1981) Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. European Journal of Pharmacology, 73, 143-154.
15. Connell PH (1958) Amphetamine psychosis. Chapman and Hall, London.
16. Corbett R, Hartman H, Kerman LL, Woods AT, Strupczewski JT, Helsley GC, Conway PC and Dunn RW (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacology Biochemistry and Behavior, 45, 9-17.
17. Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? British Medical Journal, 280, 66-68.
18. Crow TJ (1989) A current view of the type ii syndrome: age of onset, intellectual impairment, and the meaning of structural changes in the brain. British Journal of Psychiatry, 155 (Suppl. 7), 15-20.
19. Davies BM and Beech HR (1960) The effects of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers. Journal of Mental Science, 106, 912-914.
20. Ellenbroek BA, Willemen APM and Cools AR (1989) Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology, 2, 191-199.
21. Ellinwood EH (1967) Amphetamine psychosis: I. Description of the individuals and process. Journal of Nervous and Mental Disorders, 144, 273-283.
22. Ellison G, Eison MS and Huberman HS (1978) Stages of constant amphetamine intoxication: delayed appearance of abnormal social behaviors in rat colonies. Psychopharmacology, 56, 293-299.
23. Ellison G, Nielsen EB and Lyon M (1981) Animal model of psychosis: hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. Journal of Psychiatric Research, 16, 13-22.
24. Erard R, Luisada PV and Peele R (1980) The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? Journal of Psychedelic Drugs, 12, 235-251.
25. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods, 2, 219-238.
26. Fitton A and Heel RC (1990) Clozapine: a review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs, 40, 722-747.
27. Freed WJ (1988) The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity. Schizophrenia Bullitin, 14, 269-277.
28. Freed WJ (1994) Glutamatergic mechansims mediating stimulant and antipsychotic drug effects. Neuroscience and Biobehavioral Reviews, 18, 111-120.
29. Frith CD and Done DJ (1990) Stereotyped behaivour in madness and health. In: Neurobiology of Stereotyped Behaviour (Eds SJ Cooper and CT Dourish), pp. 25-63. Clarendon Press, Oxford.
30. Gerbaldo H, Helisch A, Schneider B, Philipp M and Benkert O (1994) Subtypes of negative symptoms: the primary subtype in schizophrenic and non-schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 18, 311-320.
31. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
32. Greifenstein FE, Yoshitake J, DeValut M and Gajewski JE (1958) A study of 1-aryl cyclo hexyl amine for anesthesia. Anesthesia and Analgesia, 37, 283-294.
33. Huitema BE (1980) The Analysis of Covariants and Alternatives. Wiley and Sons, New York.
34. Itil T, Keskiner A, Kiremitci N and Holden JMC (1967) Effect of phencyclidine in chronic schizophrenics. Canadian Psychiatric Association Journal, 12, 209-212.
35. Jackson DM, Johansson C, Lindgren LM and Bengtson A (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology Biochemistry and Behavior, 41, 465-471.
36. Javitt DC and Zukin SR (1991) Recent advances in the phen-cyclidine model of schizophrenia, American Journal of Psychiatry, 148, 1301-1308.
37. Jönsson LE and Gunne LM (1970) Clinical studies of amphetamine psychosis. In: International Symposium on Amphetamines and Related Compounds (Eds E Costa and S Garatitini), pp. 929-936. Raven Press, New York.
38. Kane J, Honigfeld G, Singer J and Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 49, 789-796.
39. Kesner RP and Dakis M (1993) Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task. Pharmacology Biochemistry and Behavior, 44, 419-424.
40. Kramer JC, Fisherman VS and Littlefield DC (1967) Amphetamine abuse. Journal of the American Medical Association, 201, 89-93.
41. Levy L, Cameron DE and Aitken RCB (1960) Observation on two psychotomimetic drugs of piperidine derivation - CI 395 (Sernyl) and CI 400. American Journal of Psychiatry, 116, 843-845.
42. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS and Kelley R (1959) Study of a new schizophrenomimetic drug - sernyl. American Medical Association's Archives of Neurology and Psychiatry, 81, 363-369.
43. Lyon M (1991) Animal models of mania and schizophrenia. In: Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives (Eds. P Willner), pp. 253-310. Cambridge University Press, Cambridge.
44. Machiyama Y, Utena H and Kikuchi M (1970) Behavioural disorders in Japanese monkeys produced by the long-term administration of methamphetamine. Proceedings of Japan Academy, 46, 738-743.
45. McLaren S, Cookson JC and Silverstone T (1992) Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. International Clinical Psychopharmacology, 1, 67-72.
46. Meltzer HY (1991) The mechanism of action of novel antipsychotic drugs. Schizophrenia Bulletin, 17, 263-287.
47. Meltzer HY, Alphs LD, Bastani B, Ramirez LF and Kwon K (1991) Clinical efficacy of clozapine in the treatment of schizophrenia. Pharmacopsychiatry, 24, 44-45.
48. Möller HJ, van Praag HM, Aufdembrinke B, Bailey P, Barnes TRE, Beck J, Bentsen H, Eich FX, Farrow L, Fleischhacker WW, Gerlach J, Grafford K, Hentschel B, Hertkorn A, Heylen S, Lecrubier Y, Leonard JP, McKenna P, Maier W, Pedersen V, Rappard A, Rein W, Ryan J, Sloth Nielsen M, Stieglitz RD, Wegener G and Wilson J (1994) Negative symptoms in schizophrenia: considerations for clinical trials. Psychopharmacology, 115, 221-228.
49. Morpurgo C and Theobald W (1964) Influence of antiparkinsonian drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia, 6, 178-191.
50. Murray TF and Horita A (1979) Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sciences, 24, 2217-2226.
51. Pearlson GD (1981) Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse. The John Hopkins Medical Journal, 148, 25-33.
52. Raskin A, Pelchat R, Sood R, Alphs LD and Levine J (1993) Negative symptoms assessment of chronic schizophrenia patients. Schizophrenia Bulletin, 19, 627-635.
53. Rothman RB (1994) PCP Site 2: a high affinity MK-801-insensitive phencyclidine binding site. Neurotoxicology and Teratology, 16, 343-353.
54. Russell JW, Greenberg BD and Segal DS (1984) The effects of phencyclidine on spontaneous aggressive behavior in the rat. Biological Psychiatry, 19, 195-202.
55. Sams-Dodd F (1994) Phencyclidine-induced social isolation in rats: a possible animal model for negative symptoms? Behavioural Pharmacology, 5, 125.
56. Sams-Dodd F (1995a) Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behavioural Pharmacology, 6, 55-65.
57. Sams-Dodd F (1995b) Automation of the social interaction test by a video tracking system: behavioural effects of repeated phencyclidine treatment. Journal of Neuroscience Methods, 59, 157-168.
58. Schiörring E (1977) Changes in individual and social behavior by amphetamine and related compounds in monkeys and man. In: Cocaine and Other Stimulants (Eds EH Ellinwood and MM Kilbey), pp. 481-522. Plenum Press, New York.
59. Schlemmer RF, Jackson JA, Preston KL, Bederka JP, Garver DL and Davis JM (1978) Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide. European Journal of Pharmacology, 52, 379-384.
60. Siegel RK (1978) Phencyclidine and ketamine intoxication a study of 4 populations of recreational users. In: National Institute of Drug Abuse Research Monograph #21 (Eds RC Peterson and RC Stillman), pp. 119-147. NIH Press, Washington DC.
61. Smith RC, Biggs C, Vroulis G and Brinkman S (1981) Effects of chronic administration of phencyclidine on stereotyped and ataxic behaviors in the rat. Life Sciences, 28, 1163-1174.
62. Snyder SH (1973) Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. American Journal of Psychiatry, 130, 61-67.
63. Steinpreis RE, Sokolowski JD, Papanikolaou A and Salamone JD (1994a) The effects of haloperidol and clozapine on PCP-and amphetamine-induced suppression of social behavior in the rat. Pharmacology Biochemistry and Behavior, 47, 579-585.
64. Steinpreis RE, Kuppinger HE, Panos JJ and Hollenberg D (1994b) Determining the source of PCP-induced social withdrawal in the rat. Society for Neuroscience Abstract, 20, 169.
65. Sturgeon RD, Fessler RG and Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behaviour and ataxia in rats. European Journal of Pharmacology, 59, 169-179.
66. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D and Duncan JS (1993) The excitatory aminoacid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Research, 16, 165-174.
67. Verebey K, Kogan MJ and Mule SJ (1981) Phencyclidine-induced stereotypy in rats: effects of methadone, apomorphine and naloxone. Psychopharmacology, 75, 44-47.